Abstract:Objective: Genome-wide association studies (GWAS) have uncovered specific genetic variants of the coiled-coil domain containing 92 (CCDC92) gene that are associated with coronary artery disease (CAD) and type 2 diabetes. However, the biological function of CCDC92 in cardiovascular disease (CVD) remains unclear. This study aims to investigate the impact of CCDC92 on atherosclerosis, a leading cause of CVD, and dissect underlying mechanisms. Methods and Results: To investigate the effects of CCDC92 on atherosclerosis development in vivo , we used Ccdc92 knockout (KO) mice and littermate wild type (WT) mice (in ApoE KO background) fed a high-cholesterol diet (HCD) for 18 weeks. Ccdc92 KO significantly reduced atherosclerotic plaque by sixty percent compared with littermate control mice measured by en face analysis of atherosclerotic lesions in the aortic tree after Oil Red O staining (n=11-12/group, p < 0.001). To provide a comprehensive characterization of cellular identity within the atherosclerotic lesion, we applied single-cell sequencing (scRNA-seq) to the whole atherosclerotic aorta from Ccdc92 KO/ ApoE KO and littermate control mice on HCD for 12 weeks. The scRNA-seq analysis identified 12 cell subpopulations in the atherosclerotic aorta. Cell-specific gene set enrichment analysis further indicated that Ccdc92 deficiency had protective effects on multiple vascular cell subpopulations. Specifically, in subpopulations of endothelial cells (ECs), CCDC92 regulates cell inflammation and fatty acid metabolism. Using human coronary artery ECs (HCAECs) and mouse aortic EC from Ccdc92 KO and WT mice, we demonstrated that deletion of CCDC92 significantly inhibited proinflammatory adhesion molecules and cytokines induced by TNF-α. Interestingly, Adenovirus-mediated CCDC92 overexpression increased lipid droplet accumulation (to an average of 4-fold increase) in HCAECs exposed to oleic acid overload. Conclusions: Our findings revealed the proatherogenic effects of CCDC92 in vivo and demonstrated a critical role of CCDC92 in EC dysfunction during atherosclerosis development. These data address an important new mechanism associated with atherosclerosis and provide a potential new target for atherosclerotic disease.

Abstract 101: Genetic Ablation Of CCDC92 Protects Against Vascular Inflammation And Atherosclerosis